Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Evaluation of the acceptability of improved supplementary foods for the treatment of moderate acute malnutrition in Burkina Faso using a mixed method approach

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Iuel-Brockdorf, A-S, Draebel, TA, Ritz, C, Fabiansen, C, Cichon, B, Brix Christensen, V, Yameogo, C, Oummani, R, Briend, A, Michaelsen, KF, Ashorn, P, Filteau, S & Friis, H 2016, 'Evaluation of the acceptability of improved supplementary foods for the treatment of moderate acute malnutrition in Burkina Faso using a mixed method approach' Appetite, vol. 99, pp. 34-45. https://doi.org/10.1016/j.appet.2015.12.030

APA

CBE

MLA

Vancouver

Author

Iuel-Brockdorf, Ann-Sophie ; Draebel, Tania Aase ; Ritz, Christian ; Fabiansen, Christian ; Cichon, Bernardette ; Brix Christensen, Vibeke ; Yameogo, Charles ; Oummani, Rouafi ; Briend, André ; Michaelsen, Kim F ; Ashorn, Per ; Filteau, Suzanne ; Friis, Henrik. / Evaluation of the acceptability of improved supplementary foods for the treatment of moderate acute malnutrition in Burkina Faso using a mixed method approach. In: Appetite. 2016 ; Vol. 99. pp. 34-45.

Bibtex

@article{231ba14c2dd8459f8fd766215afb16f5,
title = "Evaluation of the acceptability of improved supplementary foods for the treatment of moderate acute malnutrition in Burkina Faso using a mixed method approach",
abstract = "The objective of this study was to evaluate, within the context of a randomized controlled trial of product effectiveness, the acceptability of new formulations of six corn-soy blended flours (CSB) and six lipid-based nutrient supplements (LNS) with different quantities of milk and qualities of soy for the treatment of children with moderate acute malnutrition (MAM). Our study included 1546 children aged 6-23 months and involved questionnaires after one month of supplementation home visits and interviews with a sub-sample of 20 trial participants and their caretakers, and nine focus group discussion. All 12 products were well accepted in terms of organoleptic qualities and received good ratings. However, LNS were more appreciated by caretakers and children. Additionally, an effect of soy isolate was detected on child appreciation where products with high milk content also received better ratings. CSB were not consumed as readily; 33.9{\%} (n = 257) of children receiving CSB were reported to have leftovers compared to 17.3{\%} (n = 134) of children receiving LNS (p=<0.001). Both CSB and LNS were referred to as foods with medicinal properties and perceived as beneficial to child health. They were both reported to have high priority in the daily feeding of the child. In conclusion, there were minimal differences in acceptability of the various CSB and LNS formulations, although CSB were less readily consumed and required smaller meal volumes. Since all products were well-accepted, decisions regarding whether the more expensive products should be used for the treatment of MAM will need to be based on their effect on child nutrition, growth and health. Future supplementary feeding programs in similar contexts could furthermore consider introducing supplementary foods as a medical treatment, as this may increase adherence and decrease sharing.",
keywords = "Animals, Burkina Faso, Consumer Behavior, Dietary Fats, Dietary Proteins, Dietary Supplements, Female, Focus Groups, Food Preferences, Food, Fortified, Humans, Infant, Infant Nutritional Physiological Phenomena, Male, Meals, Micronutrients, Milk, Severe Acute Malnutrition, Soybeans, Surveys and Questionnaires, Taste, Treatment Outcome, Zea mays, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't",
author = "Ann-Sophie Iuel-Brockdorf and Draebel, {Tania Aase} and Christian Ritz and Christian Fabiansen and Bernardette Cichon and {Brix Christensen}, Vibeke and Charles Yameogo and Rouafi Oummani and Andr{\'e} Briend and Michaelsen, {Kim F} and Per Ashorn and Suzanne Filteau and Henrik Friis",
note = "Copyright {\circledC} 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.appet.2015.12.030",
language = "English",
volume = "99",
pages = "34--45",
journal = "Appetite",
issn = "0195-6663",
publisher = "Elsevier BV",

}

RIS

TY - JOUR

T1 - Evaluation of the acceptability of improved supplementary foods for the treatment of moderate acute malnutrition in Burkina Faso using a mixed method approach

AU - Iuel-Brockdorf, Ann-Sophie

AU - Draebel, Tania Aase

AU - Ritz, Christian

AU - Fabiansen, Christian

AU - Cichon, Bernardette

AU - Brix Christensen, Vibeke

AU - Yameogo, Charles

AU - Oummani, Rouafi

AU - Briend, André

AU - Michaelsen, Kim F

AU - Ashorn, Per

AU - Filteau, Suzanne

AU - Friis, Henrik

N1 - Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The objective of this study was to evaluate, within the context of a randomized controlled trial of product effectiveness, the acceptability of new formulations of six corn-soy blended flours (CSB) and six lipid-based nutrient supplements (LNS) with different quantities of milk and qualities of soy for the treatment of children with moderate acute malnutrition (MAM). Our study included 1546 children aged 6-23 months and involved questionnaires after one month of supplementation home visits and interviews with a sub-sample of 20 trial participants and their caretakers, and nine focus group discussion. All 12 products were well accepted in terms of organoleptic qualities and received good ratings. However, LNS were more appreciated by caretakers and children. Additionally, an effect of soy isolate was detected on child appreciation where products with high milk content also received better ratings. CSB were not consumed as readily; 33.9% (n = 257) of children receiving CSB were reported to have leftovers compared to 17.3% (n = 134) of children receiving LNS (p=<0.001). Both CSB and LNS were referred to as foods with medicinal properties and perceived as beneficial to child health. They were both reported to have high priority in the daily feeding of the child. In conclusion, there were minimal differences in acceptability of the various CSB and LNS formulations, although CSB were less readily consumed and required smaller meal volumes. Since all products were well-accepted, decisions regarding whether the more expensive products should be used for the treatment of MAM will need to be based on their effect on child nutrition, growth and health. Future supplementary feeding programs in similar contexts could furthermore consider introducing supplementary foods as a medical treatment, as this may increase adherence and decrease sharing.

AB - The objective of this study was to evaluate, within the context of a randomized controlled trial of product effectiveness, the acceptability of new formulations of six corn-soy blended flours (CSB) and six lipid-based nutrient supplements (LNS) with different quantities of milk and qualities of soy for the treatment of children with moderate acute malnutrition (MAM). Our study included 1546 children aged 6-23 months and involved questionnaires after one month of supplementation home visits and interviews with a sub-sample of 20 trial participants and their caretakers, and nine focus group discussion. All 12 products were well accepted in terms of organoleptic qualities and received good ratings. However, LNS were more appreciated by caretakers and children. Additionally, an effect of soy isolate was detected on child appreciation where products with high milk content also received better ratings. CSB were not consumed as readily; 33.9% (n = 257) of children receiving CSB were reported to have leftovers compared to 17.3% (n = 134) of children receiving LNS (p=<0.001). Both CSB and LNS were referred to as foods with medicinal properties and perceived as beneficial to child health. They were both reported to have high priority in the daily feeding of the child. In conclusion, there were minimal differences in acceptability of the various CSB and LNS formulations, although CSB were less readily consumed and required smaller meal volumes. Since all products were well-accepted, decisions regarding whether the more expensive products should be used for the treatment of MAM will need to be based on their effect on child nutrition, growth and health. Future supplementary feeding programs in similar contexts could furthermore consider introducing supplementary foods as a medical treatment, as this may increase adherence and decrease sharing.

KW - Animals

KW - Burkina Faso

KW - Consumer Behavior

KW - Dietary Fats

KW - Dietary Proteins

KW - Dietary Supplements

KW - Female

KW - Focus Groups

KW - Food Preferences

KW - Food, Fortified

KW - Humans

KW - Infant

KW - Infant Nutritional Physiological Phenomena

KW - Male

KW - Meals

KW - Micronutrients

KW - Milk

KW - Severe Acute Malnutrition

KW - Soybeans

KW - Surveys and Questionnaires

KW - Taste

KW - Treatment Outcome

KW - Zea mays

KW - Journal Article

KW - Randomized Controlled Trial

KW - Research Support, Non-U.S. Gov't

U2 - 10.1016/j.appet.2015.12.030

DO - 10.1016/j.appet.2015.12.030

M3 - Journal article

VL - 99

SP - 34

EP - 45

JO - Appetite

JF - Appetite

SN - 0195-6663

ER -

ID: 49872968